Armstrong D - Search Results

1

Three-drug synergistic inhibition of HIV-1 replication in vitro by 3'-fluoro-3'-deoxythymidine, recombinant soluble CD4, and recombinant interferon-alpha.

Pan XZ, Qiu ZD, Baron PA, Gold JW, Polsky B, Chou TC, Armstrong D. Pan XZ, et al. Among authors: armstrong d. AIDS Res Hum Retroviruses. 1992 May;8(5):589-95. doi: 10.1089/aid.1992.8.589. AIDS Res Hum Retroviruses. 1992. PMID: 1515212

2

Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.

Kong XB, Zhu QY, Ruprecht RM, Watanabe KA, Zeidler JM, Gold JW, Polsky B, Armstrong D, Chou TC. Kong XB, et al. Among authors: armstrong d. Antimicrob Agents Chemother. 1991 Oct;35(10):2003-11. doi: 10.1128/AAC.35.10.2003. Antimicrob Agents Chemother. 1991. PMID: 1722077 Free PMC article.

3

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.

Kong XB, Zhu QY, Vidal PM, Watanabe KA, Polsky B, Armstrong D, Ostrander M, Lang SA Jr, Muchmore E, Chou TC. Kong XB, et al. Among authors: armstrong d. Antimicrob Agents Chemother. 1992 Apr;36(4):808-18. doi: 10.1128/AAC.36.4.808. Antimicrob Agents Chemother. 1992. PMID: 1503443 Free PMC article.

4

An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).

Povolotsky J, Gold JW, Darminin P, Chein N, Baron P, Armstrong D. Povolotsky J, et al. Among authors: armstrong d. J Virol Methods. 1990 Oct;30(1):109-14. doi: 10.1016/0166-0934(90)90048-k. J Virol Methods. 1990. PMID: 2128300

5

Inactivation of human immunodeficiency virus in vitro by gossypol.

Polsky B, Segal SJ, Baron PA, Gold JW, Ueno H, Armstrong D. Polsky B, et al. Among authors: armstrong d. Contraception. 1989 Jun;39(6):579-87. doi: 10.1016/0010-7824(89)90034-6. Contraception. 1989. PMID: 2473865

6

Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions.

Povolotsky J, Gold JW, Chein N, Baron P, Armstrong D. Povolotsky J, et al. Among authors: armstrong d. J Infect Dis. 1991 Feb;163(2):247-51. doi: 10.1093/infdis/163.2.247. J Infect Dis. 1991. PMID: 1899100

7

Fluorinated sugar analogues of potential anti-HIV-1 nucleosides.

Huang JT, Chen LC, Wang LB, Kim MH, Warshaw JA, Armstrong D, Zhu QY, Chou TC, Watanabe KA, Matulic-Adamic J, et al. Huang JT, et al. Among authors: armstrong d. J Med Chem. 1991 May;34(5):1640-6. doi: 10.1021/jm00109a017. J Med Chem. 1991. PMID: 2033590

8

Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.

Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. Grant IH, et al. Among authors: armstrong d. AIDS. 1990 Jun;4(6):519-21. AIDS. 1990. PMID: 2386617

9

Peptide T does not inhibit HIV-1 infection in an in vitro serum-free system.

Baron PA, Polsky B, Gold JW, Zuckerman EE, Hardy WD Jr, Meyer-Glauner W, Armstrong D. Baron PA, et al. Among authors: armstrong d. AIDS. 1988 Jun;2(3):227-8. AIDS. 1988. PMID: 3134920 No abstract available.

10

HIV-related emergencies: frequency, diagnoses, and outcome.

Chang R, Wong G, Gold J, Armstrong D. Chang R, et al. Among authors: armstrong d. J Gen Intern Med. 1993 Sep;8(9):465-9. doi: 10.1007/BF02600105. J Gen Intern Med. 1993. PMID: 8410417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,671 results

Search Page

Filters